Agenus corporate update and fourth quarter & full year 2020 financial report

Lexington, mass., march 15, 2021 (globe newswire) --  agenus inc. (nasdaq: agen), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today provided a corporate update and reported financial results for the fourth quarter and full year 2020.
AGEN Ratings Summary
AGEN Quant Ranking